Since the anti-cancer effects of SGLT2 inhibitors may depend on the type of cancer and/or the type of SGLT2 inhibitor, further research focusing on the dependence and difference described above may be able to clarify detailed mechanisms. The gene discussed is SLC5A2; the disease is cancer.